Skip to main content
Download PDF

Does human milk composition predict later risk of obesity? A systematic review

BMC Nutrition volume 9, Article number: 89 (2023) Cite this article

Abstract

Background

Possible mechanisms behind the association of breastfeeding with a lower risk of later obesity are unknown but one possibility is the unique composition of human milk. Here, we systematically reviewed the evidence linking breast-milk macronutrient and hormonal composition with later obesity.

Methods

We searched 7 databases for studies that included infants predominantly breast-fed for the first 3 months and which analysed associations between a measure of breast-milk composition and later (> 6 months) measures of obesity or body composition.

Results

47 publications were identified for full-text screening, of which 10 were eligible and only 3 found significant associations. Higher leptin concentration in breast milk at age 1 month was associated with lower infant BMI at 12, 18 and 24 months of age (1 study). Higher breast-milk adiponectin concentration at 6 weeks and 4 months were associated with adiposity at age 12 and 24 months (1 study). In 1 study, breast-milk carbohydrate content was positively associated, and fat content negatively associated, with adiposity at age 12 months. No significant associations were found between other hormones or macronutrients in human milk and later risk of obesity or body composition.

Conclusions

The evidence linking breast-milk composition with later obesity was inconsistent and confined to single, individual studies. Our review highlights the methodological limitations of previous studies and the need for further research in this area.

Peer Review reports

Background

Obesity in children is a major global public health issue with an estimated 16% of children and adolescents, and 38.2 million children under 5 years, living with overweight or obesity globally [1]. Children who have overweight and obesity are more likely to stay overweight and obese into adulthood and are at higher risk of developing non-communicable diseases such as cardiovascular disease and type 2 diabetes at an earlier age than in children without obesity. While genetic, environmental and lifestyle factors are the major determinants [2], there is compelling evidence that factors acting during a critical window in the ‘first 1000 days’, the period from conception to 2 years of age, also influence or ‘programme’ the risk of later obesity [3], a concept known as the developmental origins of health and disease hypothesis [4]. Early postnatal nutrition has shown to have strong programming effects with several systematic reviews finding a lower risk of obesity in breast-fed compared to formula-fed infants [5, 6]. However, whether breastfeeding is causally related to a lower risk of obesity is controversial, partly because the potential mechanisms remain poorly understood, and because of the possibility of confounding factors (e.g. maternal education) influencing both a mother’s decision to breast-feed and lifestyle risk factors for developing obesity [7,8,9].

The protective effect of breastfeeding against obesity has been suggested to be partly explained by its unique composition [10, 11]. For example, a lower concentration of protein in human milk compared to formula is suggested to lead to a slower pattern of weight gain and, in turn, reduce the later risk of obesity, as described in the postnatal growth acceleration hypothesis [12]. Higher protein intake in infant formula could increase concentrations of insulin and insulin-like growth factor 1 (IGF-1), stimulating both accelerated growth and adipogenesis as described in the early protein hypothesis [13, 14]. Other factors found in human milk that are associated with infant growth and later obesity include human milk oligosaccharides (HMO), long-chain polyunsaturated fatty acids (LCPUFA), and hormones such as leptin, insulin, ghrelin, and adiponectin. However, whether these factors are causally related to a lower risk of obesity in breast-fed infants remains unknown [15,16,17].

The potential role of confounding factors in explaining the lower risk of obesity in breast-fed versus formula-fed infants may be partly addressed by investigating associations between human milk composition and later obesity within a predominantly breast-fed population. In one such study, Prentice et al. showed that a lower concentration of fat in human milk at 4–8 weeks of age was associated with greater gains in BMI and adiposity in the first year, whilst higher carbohydrates and protein concentrations were both associated with a higher BMI at age 12 months, with the same pattern of associations observed in the sub-analysis consisting of infants exclusively breastfed [18]. In contrast, Gridneva et al. (2018) found that the concentration of protein in human milk was not associated with body composition at age 12 months [19]. Thus, whether human milk composition impacts later obesity and body composition remains unknown.

Previous reviews have investigated the effects of human milk hormones or macronutrients on short-term infant growth and body composition but not on later risk of obesity [20,21,22]. As such, the aim of this systematic review was to synthesize the existing literature on associations between human milk nutritional composition and later measures of obesity, obesity risk or body composition beyond infancy. Findings from such a review could help to better understand the mechanisms for the beneficial effects of breastfeeding on later health and inform targeted prevention strategies for obesity (e.g., prevention of overfeeding) in both breast-fed and formula-fed infants.

Methods

This systematic review was reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement (PRISMA) [23]. The PRISMA 2020 checklist shows this (see Additional File 1). The protocol was registered in PROSPERO (registration number: CRD42020193664).

Eligibility criteria

Only studies published in English were included as this was the native language of the reviewers. All cohort studies including longitudinal, prospective cohort, birth cohorts or pilot studies were eligible. Randomized controlled trials (RCTs) and quasi-randomized controlled trials of mothers who received nutritional supplementation (e.g., long-chain polyunsaturated fatty acids [LCPUFA], or human milk oligosaccharides [HMO]) before and during lactation, and where there was a subsequent measure of human milk composition and later risk of obesity, or body composition were included. Data from RCTs were treated as a cohort because only associations between human milk composition and later measures of obesity or body composition were of interest. RCTs which supplemented micronutrients were excluded because these nutrients have not been hypothesized to be associated with a later risk of obesity in breast-fed or formula-fed infants. Studies where only the abstract was available were excluded as the authors would not be able to extract the relevant data.

Studies in which most (> 75%) infants were exclusively or predominantly breast-fed (defined as receiving < 125 ml formula/day) for the first three months were eligible. Populations predominantly breast–feeding (as opposed to exclusively breast-fed) were chosen as an eligibility criterion since in many populations mixed feeding is common whereas exclusive breast-feeding is relatively rare. Due to the scarcity of studies that included exclusive or predominantly breastfed infants with a measure of human milk composition, and in order not to exclude potentially relevant studies, no restrictions were made on study country or setting or participant ethnicity. Excluded studies included animal models, infants < 37 weeks’ gestation, infants born small for gestation (defined as birthweight < 2 SD below the mean, or < 10th percentile according to the growth charts used), and infants with clinical conditions or chronic disease that could influence patterns of growth.

Eligible studies were those which measured human milk components expressed as a whole or its constituent parts including energy, protein (total protein and/or amino acids), lipids (total lipids and/or triglycerides, fatty acids), carbohydrates (total carbohydrates and/or glucose, lactose, fructose, HMO), LCPUFA of the omega-6 (n-6) series (linoleic acid and arachidonic acid and omega-3 (n-3) series (α-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid), leptin, insulin, adiponectin, ghrelin, and cortisol. Only studies analysing mature milk, and not colostrum were considered eligible because colostrum composition is highly variable over time, and has relatively low concentrations of lactose, lipids, and energy, in line with its mainly immunological rather than nutritional function [24].

The primary outcome was an association between a measure of obesity or obesity risk captured ≥ 6 months (± 2 weeks) after the associated measure of human milk composition. A gap of 6 months between exposure and outcome was chosen arbitrarily to assess ‘later’ or ‘programming’ effects of breast milk composition on obesity. Acceptable measures of obesity or obesity risk included body mass index (BMI), BMI percentile, and BMI z-score in children < 18 years, and BMI in adults, obtained at a specific time point or analysed as the change between two time points. Since there are different growth charts and BMI cut-offs for obesity, all definitions for obesity based on any growth chart were accepted. The secondary outcome was associations between a measure of body composition captured ≥ 6 months (± 2 weeks) after the associated measure of human milk composition. Measures of body composition, reported either as an absolute value at a specific time point, or as a change between two time points, were acceptable. These measures included skinfold thickness (any number of sites), or any more sophisticated techniques to quantify fat and fat free mass (e.g., deuterium dilution), expressed as an absolute amount or as in any index (e.g., fat mass index).

Information sources

Studies were identified by searching electronic databases with initially no restrictions applied on language, date, or publication status. The electronic databases searched included Cochrane Central Register of Controlled Trials (CENTRAL; current issue) part of the Cochrane Library, MEDLINE Ovid (from 1946), Embase Ovid (from 1974), Maternity and Infant Care (MIDIRS) (from 1971), PubMed (from 1982), Web of Science Core Collection Clarivate (1990 onwards) and SCOPUS Elsevier (1979 onwards).

Search strategy

The search strategy included database-specific terms and medical subject headings (MeSH) with Boolean operators, truncations, wildcards, and synonyms of terms relating to human milk, obesity, anthropometry, hormones, and macronutrients. Searches were limited to human studies and excluded measures of cognition, infection, complementary feeding, and breast-feeding duration. In addition, reference lists of studies in full-text review were searched to identify possible omissions. The search was updated on 26 April 2023. Full search results are available (see Additional File 2).

Selection strategy

Studies retrieved from the search were uploaded to the reference management system EndNote X9 3.3 before being transferred to the Covidence system for duplicate removal and screening. Eligibility assessment was conducted by two independent reviewers (MDP and MG) in a two-stage process. Titles and abstracts were screened first and studies that met inclusion criteria underwent full-text review. Disagreements between reviewers were resolved through consultation with a third reviewer (JL).

Data collection

Data to be extracted was agreed a priori by the research team. Two reviewers (MDP and MG) extracted data independently and any inconsistencies and disagreements were resolved through mutual discussion. Where necessary, authors were contacted for clarification (on 2 occasions and with one response). Extracted data included author name, date of publication, source of study funding and conflicts of interest, study design, aim, duration, population, feeding type and duration, timing and type of human milk component, obesity and anthropometric measures, results of associations and confounders.

Quality assessment

Two independent reviewers (MDP and MG) used the revised Downs and Black Quality Index score system, known to be a valid and reliable tool for assessing bias in randomized and observational studies to assess the quality of individual publications [25]. Item 27 relating to statistical power was modified so that a score of 1 was given where a power calculation was performed and 0 if this was not the case [26]. The maximum total quality score using this system was 28, a score of ≥ 26 was considered excellent, a score between 20 – 25 was considered good, 15 – 19 was considered fair, and a score ≤ 14 was considered low [27]. The quality assessment tool provided an overall quality score based on four assessed domains including reporting, external validity, internal validity bias and internal validity-confounding [25]. Any disagreements were resolved through discussion.

Results

Study selection

We identified 2235 papers, of which 1103 were screened following the removal of duplicates, with the remaining 47 eligible for full-text assessment. In total, 10 papers [18, 19, 28,29,30,31,32,33,34,35] were included in the narrative synthesis from 9 original studies [18, 19, 28,29,30,31, 33,34,35]. Meyer et al. [32] was a later follow-up from the same cohort reported in Brunner et al. [28], and three of the papers were original analysis involving the same population [19, 30, 31]. See Fig. 1 for PRISMA flow diagram.

Fig. 1
figure 1

Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow diagram summarizing the process of study screening and reasons for exclusion

Full size image

Data synthesis

Once the data from eligible studies were extracted it became clear that it was not possible to conduct a meta-analysis on the relationship between human milk composition and later obesity due to the highly heterogenic data for both measures of human milk composition and obesity. As such, data was synthesized narratively and presented in tabular format.

Study characteristics

All included studies were conducted in high-income countries, and most were of cohort design [18, 19, 29,30,31, 33,34,35]. Two studies were follow-ups of a previously conducted RCT [28, 32]. Human milk components analysed included concentrations of leptin [28, 30, 32, 33], adiponectin [28, 30, 32], carbohydrates [18, 29, 31, 34, 35], protein [18, 19, 29, 34, 35], fat [18, 29, 34, 35], energy [18, 34], insulin, principal component analysis (PCA) of fatty acids, and LCPUFA n-6 to n-3 ratio [29]. There were no eligible studies found for ghrelin, cortisol, or HMO concentrations. Data for all eligible studies including the methods for collection and analysis of human milk samples and measurements of obesity and/or body composition are summarised (see Additional file 3).

Quality assessment

Quality assessment scores are found in Table 1. Included papers were of low to fair quality with scores ranging from 7 to 18 (mean, SD: 14.2, 3.1). The average score for the reporting section (maximum 11) was mediocre, with a mean score of 7 ± 1.25. The external validity rating was poor across most studies with a mean score of 0.8 ± 1.1 out of a maximum of 3. The internal validity bias rating was average, (with a mean score of 3.9 ± 0.9 out of a maximum of 7) because, as expected, none of the studies blinded study subjects or researchers to the exposure (human milk composition). In assessing the internal validity—confounding, the mean score was 2.1 ± 0.8 from a maximum score of 6. Only 6 of the chosen publications adjusted for confounding variables in the analysis [18, 28, 29, 32, 34, 35]. Lastly, only 4 studies conducted a power calculation, which scored an extra 1 point [19, 30, 31, 35].

Table 1 Risk of bias assessment
Full size table

Synthesis of results

Results of associations between human milk composition and later measures of obesity were summarised (see Additional file 4). Eight out of the 10 selected papers reported associations between human milk composition and later measures of BMI [19, 28,29,30,31,32,33, 35]. Of these, only Miralles et al. [33] reported an association between higher concentration of leptin in human milk at 1 month of age and a lower BMI at age 12, 18, and 24 months. In contrast, Brunner et al. [28] found no significant associations between either human milk leptin concentration at age 4 months, or adiponectin concentration at age 6 weeks and infant BMI at 12 or 24 months of age. Likewise, Gridneva et al. [30] found no significant association between calculated daily intakes of leptin between 2 and 5 months of age and change in infant BMI (kg/m2) between 2 and 12 months, or between 5 and 12 months. Meyer et al. [32] also reported no significant associations between both 6-week leptin or adiponectin concentrations and BMI percentile at age 3–5 years. No significant associations were found between other hormones or macronutrients in human milk and later risk of obesity [19, 29, 31, 35].

Results of associations between human milk composition and later measures of body composition were summarised (see Additional file 5). Eight of the 10 chosen papers investigated associations between human milk composition and later body composition [18, 19, 28, 30,31,32, 34, 35]. Prentice et al. [18] found that higher carbohydrate content in human milk (expressed as percentage of total energy) at age 4–8 weeks was associated with adiposity at 12 months of age while a higher percentage of fat in human milk at 4–8 weeks of age was associated with lower adiposity at age 12 months. However, there were no significant associations between the protein or energy content of human milk and later adiposity [18]. Equally, Olga et al. found no significant association with carbohydrate, protein or fat at 6 weeks and sum of four skinfold SDS at 12 months in infants exclusively breast fed for the first 6 months [35]. In terms of hormones, Brunner et al. [28] reported that a higher concentration of adiponectin in human milk when the infant was aged 6 weeks was associated with higher fat mass (expressed as sum of four skinfolds, total fat mass and percentage body fat) at age 12 months, but not at 24 months of age. The concentration of adiponectin in human milk at 4 months of age was also associated with greater fat mass (expressed as sum of skinfolds at four sites, absolute and percentage body fat) at 24 months of age in the adjusted analyses. In contrast, Meyer et al. and Gridneva et al. [30, 32] found no association between human milk adiponectin concentration measured at several time points and adiposity between 2 and 12 months, and 5 and 12 months [30], or later in childhood at 3, 4, 5 years of age [32]. No significant associations were reported for the concentration of leptin in human milk at age 4 months and measures of body composition at 12 or 24 months of age [28]. No other publications reported significant associations between other hormones [30, 32] or macronutrient concentrations and later body composition after statistical adjustment for multiple testing [19, 31, 34, 35]. Few eligible studies adjusted for confounding factors in the analysis [18, 28, 32, 34, 35]. However, Brunner et al. confirmed that the association between adiponectin and adiposity measured at 1 year remained significant after adjustment for maternal pre-pregnancy BMI, gestational weight gain, sex, and type of infant feeding (exclusively or partially breastfed) [28].

Discussion

To the best of our knowledge, this is the first systematic synthesis of the literature on longitudinal associations between breast-milk composition and later measures of obesity and body composition. Specifically, in contrast to individual studies, our systematic synthesis found little evidence of consistent associations between energy, macronutrient and hormonal content of human milk and measures of later obesity or adiposity. The review highlights the inconsistency of the evidence linking breast milk composition and later risk of obesity, the need to better understand mechanisms supporting the protective effects of breastfeeding on later obesity, and the need for further research in this area.

Previously, hormones such as adiponectin and leptin which play key roles in energy homeostasis and satiety (and are found in human milk but absent from formula) have been hypothesized to contribute to the protective effect of breast feeding against obesity [36, 37]. Leptin receptors have been identified in the gastric and absorptive cells of human and animal models, suggesting that leptin can pass from breast-milk to the bloodstream [38]. Therefore, leptin ingested in breast-milk has been proposed to influence infant energy regulation by upregulating hypothalamic neurons that reduce appetite and suppressing those that increase food intake [36]. However, of the 4 published studies that investigated the association between breast-milk leptin concentration and later obesity or body composition [28, 30, 32, 33], only Miralles et al. [33] demonstrated a negative association with later BMI in the first 24 months suggesting that this hypothesis remains uncertain. Similarly, only 1 of 3 studies found an association between human milk adiponectin concentration and later obesity or body composition [28, 30, 32]. In the only positive study, adiponectin concentration at age 6 weeks was associated with greater adiposity at age 12 months, and concentrations at age 4 months were associated with greater adiposity at 24 months [28], but not later in childhood (3–5 years of age) suggesting that any association was likely to be short-term [32]. The reasons for these inconsistent findings are uncertain, but could include the lack of understanding on how leptin and adiponectin in breast-milk reach the infant’s circulation in a biologically active form [39]. Lastly, of the papers investigating hormones, only one study investigated the concentration of insulin in human milk but reported no significant associations with later BMI [29]. Overall, the limited number of studies found in this review, and lack of consistent associations, casts doubt on the hypothesis that hormones found in breast-milk such as leptin, adiponectin or insulin influence the later risk of obesity, a finding in agreement with a recent systematic review that also found conflicting evidence on a role for human milk hormones on infant growth [40].

Surprisingly, we found limited evidence of any associations between breast-milk macronutrient composition and later obesity risk or body composition [18, 19, 29, 31, 34, 35]. Only one study [18] found that a higher percentage of fat in breast-milk was associated with lower adiposity at age 12 months while a higher percentage of carbohydrate was associated with greater adiposity at 12 months, independent of birthweight, gestational age, infant sex, nutrition type and HM storage time [18]. Possible explanations for these finding are unclear, but the authors suggested that a higher fat content in human milk may have greater satiating effect that help to better regulate the development of longer-term appetite [41]. Lastly, despite evidence for effects of LCPUFA on adipogenesis [42, 43], we found no evidence of any association between the LCPUFA content of human milk and risk of later obesity, even though LCPUFAs may have beneficial effects for other outcomes such as neurodevelopment.

Perhaps the most surprising finding was the limited evidence for any association between breast milk protein content and later obesity or body composition [18, 19, 29, 34, 35]. The study by Prentice et al. found that breast-milk protein concentration was associated with later risk of obesity in the predominantly breast-fed but not in exclusively breast-fed infants, suggesting that protein in human milk has different effects on programming of obesity than protein in formula possibly because of differences in protein quality. Due to the strict selection criteria for this review (> 75% of infant participants exclusively or predominantly breast-fed [defined as receiving < 125 ml formula/day]), only the results from the sub-analysis of exclusively breast-fed infants were included. A high protein intake in early life has been consistently associated with greater risk of obesity [14, 44] and adiposity later in life [13] in epidemiological studies [45] and RCTs in formula–fed infants [5, 14, 44, 46]. There is also anecdotal evidence in exclusively breast–fed infants that a high protein concentration in breast-milk (mean 1.25 g/dl compared to the reference of 0.8 g/dl) is associated with excessive weight gain in infancy and a higher risk of later obesity [47, 48]. However, only 5 studies have investigated associations of human milk protein concentration with risk of later obesity [18, 19, 29, 34, 35] and hence there is insufficient evidence to suggest that the early protein hypothesis is applicable to exclusively or predominantly breastfed infants.

A major strength of this review is the comprehensive and systematic assessment of the data linking human milk composition and longitudinal risk of obesity and adiposity in infancy. Another strength was the independent completion of study screening, selection, bias assessment, and data extraction by two reviewers, thereby reducing bias. Studies investigating cross-sectional associations between human milk composition and measures of obesity were specifically excluded to focus on the factors in human milk which could explain the longer-term (or ‘programming’) protective effects of breast feeding on risk of developing obesity.

This systematic review has several limitations. First, the studies used varying methods for assessing human milk composition, obesity, and body composition. Human milk components were expressed using different parameters (e.g., concentrations, percentages, daily intakes) which made comparisons between studies difficult. As such, due to this heterogeneity, it was not possible to standardise the exposures and outcomes of interest and conduct a meta-analysis. Second, most studies in this area were generally of low quality with none rated as ‘good’ or above. Third, widely variable and non-standardised methods of collecting and handling human milk samples means that human milk composition data is likely to have been affected by factors such as circadian rhythms and infant’s age. For instance, protein content decreases over the first few months following birth [49], whilst fat content of human milk is highly variable and influenced by time of day and increases throughout the feed as the breast is emptied [50]. In addition, only the Gridneva et al. studies and most recently Olga et al. considered volume of breast-milk intake, which would affect the total amount of human milk components ingested [19, 30, 31, 35]. Human milk composition is also affected by the total volume of milk. For instance, in the DARLING study, protein and lipid concentrations in human milk were lower with a higher volume of milk, whilst lactose concentration was positively related to human milk volume [41]. Fourth, only 6 of 10 studies accounted for potential confounding factors in data analyses [18, 28, 29, 32, 34, 35], an important omission given that both human milk composition and obesity risk may be influenced by maternal anthropometry and socio-demographic factors. Finally, only a small number of studies were available to review. This is partly because many studies did not define or report infant feeding practices, or the sample included a significant proportion of formula-fed infants. However, using a strict inclusion criterion of > 75% breast feeding was felt to be important because of the well-known association of formula feeding with later obesity [5, 14, 44, 46].

Conclusions

Overall, this systematic review found insufficient evidence to support the hypothesis that human milk composition is associated with later risk of obesity or body composition. The review highlights important methodological limitations of previous research and so we recommend that the following be considered in future studies in this area. First, standardized protocols for the collection and analysis of human milk samples are essential to ensure representative samples that can be compared across studies. Second, measurement of milk volume intake will be critical to assess the absolute intake of nutrients and so may provide a better mechanistic insight into the link between human milk composition and later obesity. Third, data analysis should control for known confounding variables that could affect human milk composition and measures of obesity. Future research using these recommendations could help identify infants more susceptible to developing later obesity, optimize the composition of infant formula, and inform strategies for the prevention of obesity in both breastfed and formula-fed infants.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

Abbreviations

2SF:

2-Skinfolds

4SF:

4-Skinfolds

BC:

Body composition

BIS:

Bio impedance spectroscopy

BMI:

Body mass index

CDI:

Calculated daily intake

CI:

Confidence interval

EBF:

Exclusively breastfed

EP:

Electric pump

F:

Female

FFM:

Fat-free mass

FFMI:

Fat-free mass index

FM:

Fat mass

FM/FFM:

Fat mass/fat-free mass ratio

FMI:

Fat mass index

HE:

Hand expressed

HM:

Human milk

HMO:

Human milk oligosaccharides

LCPUFA:

Long-chain polyunsaturated fatty acids

M:

Male

MeSH:

Medical subject headings

N:

Number of participants

n-3:

Omega-3

n-6:

Omega-6

NS:

Not stated

PCA:

Principal component analysis

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analysis

RCT:

Randomized controlled trial

SD:

Standard deviation

SDS:

Standard deviation scores

SF:

Skinfolds

References

  1. World Health Organization. Obesity and overweight 2020 [Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.

  2. Reddon H, Guéant JL, Meyre D. The importance of gene-environment interactions in human obesity. Clin Sci (Lond). 2016;130(18):1571–97.

    Article  CAS  PubMed  Google Scholar 

  3. Lucas A. Programming by early nutrition in man. In: Gregory RB, Whelan J, editors. The Childhood Environment and Adult Disease. United Kingdom: Wiley; 1991. p. 38–55.

    Google Scholar 

  4. Gluckman PD, Hanson MA, Buklijas T. A conceptual framework for the developmental origins of health and disease. J Dev Orig Health Dis. 2010;1(1):6–18.

    Article  CAS  PubMed  Google Scholar 

  5. Patro-Gołąb B, Zalewski BM, Kołodziej M, Kouwenhoven S, Poston L, Godfrey KM, et al. Nutritional interventions or exposures in infants and children aged up to 3 years and their effects on subsequent risk of overweight, obesity and body fat: a systematic review of systematic reviews. Obes Rev. 2016;17(12):1245–57.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015;104(S467):30–7.

    Article  CAS  PubMed  Google Scholar 

  7. Victora CG, Bahl R, Barros AJ, França GV, Horton S, Krasevec J, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.

    Article  PubMed  Google Scholar 

  8. Maharlouei NMD, Pourhaghighi AMs, Raeisi Shahraki HP, Zohoori DMD, Lankarani KBMD. Factors Affecting Exclusive Breastfeeding, Using Adaptive LASSO Regression. Int J Community Based Nurs Midwifery. 2018;6(3):260–71.

    PubMed  Google Scholar 

  9. Logan C, Zittel T, Striebel S, Reister F, Brenner H, Rothenbacher D, et al. Changing Societal and Lifestyle Factors and Breastfeeding Patterns Over Time. Pediatrics. 2016;137(5): e20154473.

    Article  PubMed  Google Scholar 

  10. Lind MV, Larnkjaer A, Molgaard C, Michaelsen KF. Breastfeeding, Breast Milk Composition, and Growth Outcomes. Nestle Nutr Inst Workshop Ser. 2018;89:63–77.

    Article  PubMed  Google Scholar 

  11. Ramadurai S, Andrews C, Cheema S, Thomas R, Wagner CL, Sen S. Maternal predictors of breast milk plasmalogens and associations with infant body composition and neurodevelopment. Clin Ther. 2022;44(7):998–1009.

    Article  CAS  PubMed  Google Scholar 

  12. Singhal A. Does breastfeeding protect from growth acceleration and later obesity? Issues in complementary feeding. 2007;60:15–29.

    Article  Google Scholar 

  13. Totzauer M, Luque V, Escribano J, Closa-Monasterolo R, Verduci E, ReDionigi A, et al. Effect of Lower Versus Higher Protein Content in Infant Formula Through the First Year on Body Composition from 1 to 6 Years: Follow-Up of a Randomized Clinical Trial. Obesity. 2018;26(7):1203–10.

    Article  CAS  PubMed  Google Scholar 

  14. Weber M, Grote V, Closa-Monasterolo R, Escribano J, Langhendries J-P, Dain E, et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr. 2014;99(5):1041–51.

    Article  CAS  PubMed  Google Scholar 

  15. Jorgensen JM, Young R, Ashorn P, Ashorn U, Chaima D, Davis JCC, et al. Associations of human milk oligosaccharides and bioactive proteins with infant growth and development among Malawian mother-infant dyads. Am J Clin Nutr. 2020;113(1):209–20.

    Article  PubMed Central  Google Scholar 

  16. Zamanillo R, Sánchez J, Serra F, Palou A. Breast milk supply of microRNA associated with leptin and adiponectin is affected by maternal overweight/obesity and influences infancy BMI. Nutrients. 2019;11(11):2589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Galante L, Lagström H, Vickers MH, Reynolds CM, Rautava S, Milan AM, et al. Sexually dimorphic associations between maternal factors and human milk hormonal concentrations. Nutrients. 2020;12(1):152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Prentice P, Ong KK, Schoemaker MH, Van Tol EAF, Vervoort J, Hughes IA, et al. Breast milk nutrient content and infancy growth. Acta Paediatrica, International Journal of Paediatrics. 2016;105(6):641–7.

    Article  CAS  Google Scholar 

  19. Gridneva Z, Tie WJ, Rea A, Lai CT, Ward LC, Murray K, et al. Human milk casein and whey protein and infant body composition over the first 12 months of lactation. Nutrients. 2018;10(9):1332.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mazzocchi A, Giannì ML, Morniroli D, Leone L, Roggero P, Agostoni C, et al. Hormones in Breast Milk and Effect on Infants’ Growth: A Systematic Review. Nutrients. 2019;11(8):1845.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Eriksen KG, Christensen SH, Lind MV, Michaelsen KF. Human milk composition and infant growth. Curr Opin Clin Nutr Metab Care. 2018;21(3):200–6.

    Article  CAS  PubMed  Google Scholar 

  22. Fields DA, Schneider CR, Pavela G. A narrative review of the associations between six bioactive components in breast milk and infant adiposity. Obesity (Silver Spring). 2016;24(6):1213–21.

    Article  PubMed  Google Scholar 

  23. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7): e1000097.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ballard O, Morrow AL. Human Milk Composition: Nutrients and Bioactive Factors. Pediatr Clin North Am. 2013;60(1):49–74.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache. 2020;60(7):1300–16.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kennelly J. Methodological approach to assessing the evidence. In: Reducing racial/ethnic disparities in reproductive and perinatal outcomes: the evidence from population-based interventions. Boston: Springer US; 2010. p. 7–19.

  28. Brunner S, Schmid D, Zang K, Much D, Knoeferl B, Kratzsch J, et al. Breast milk leptin and adiponectin in relation to infant body composition up to 2 years. Pediatr Obes. 2015;10(1):67–73.

    Article  CAS  PubMed  Google Scholar 

  29. Ellsworth L, Perng W, Harman E, Das A, Pennathur S, Gregg B. Impact of maternal overweight and obesity on milk composition and infant growth. Matern Child Nutr. 2020;(3):e12979.

  30. Gridneva Z, Kugananthan S, Rea A, Lai CT, Ward LC, Murray K, et al. Human Milk Adiponectin and Leptin and Infant Body Composition over the First 12 Months of Lactation. Nutrients. 2018;10(8):1125.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gridneva Z, Rea A, Tie WJ, Lai CT, Kugananthan S, Ward LC, et al. Carbohydrates in human milk and body composition of term infants during the first 12 months of lactation. Nutrients. 2019;11(7):1472.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Meyer DM, Brei C, Stecher L, Much D, Brunner S, Hauner H. The relationship between breast milk leptin and adiponectin with child body composition from 3 to 5years: a follow-up study. Pediatr Obes. 2017;12:125–9.

    Article  PubMed  Google Scholar 

  33. Miralles O, Sánchez J, Palou A, Picó C. A physiological role of breast milk leptin in body weight control in developing infants. Obesity (Silver Spring). 2006;14(8):1371–7.

    Article  CAS  PubMed  Google Scholar 

  34. de Fluiter KS, Kerkhof GF, van Beijsterveldt IALP, Breij LM, Hokken-Koelega ACS, van de Heijning BJM, et al. Longitudinal human milk macronutrients, body composition and infant appetite during early life. Clin Nutr. 2021;40(5):3401–8.

    Article  PubMed  Google Scholar 

  35. Olga L, Vervoort J, van Diepen JA, Gross G, Petry CJ, Prentice PM, et al. Associations between breast milk intake volume, macronutrient intake and infant growth in a longitudinal birth cohort: the Cambridge Baby Growth and Breastfeeding Study (CBGS-BF). Br J Nutr. 2023;130(1):56–64. Cambridge University Press.

  36. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8(1):21–34.

    Article  CAS  PubMed  Google Scholar 

  37. Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, et al. Adiponectin and Resistin in Human Cerebrospinal Fluid and Expression of Adiponectin Receptors in the Human Hypothalamus. J Clin Endocrinol Metab. 2007;92(3):1129–36.

    Article  CAS  PubMed  Google Scholar 

  38. Barrenetxe J, Villaro AC, Guembe L, Pascual I, Muñoz-Navas M, Barber A, et al. Distribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytes. Gut. 2002;50(6):797–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Thompson AL. Developmental origins of obesity: Early feeding environments, infant growth, and the intestinal microbiome. Am J Hum Biol. 2012;24(3):350–60.

    Article  PubMed  Google Scholar 

  40. Perrella S, Gridneva Z, Lai CT, Stinson L, George A, Bilston-John S, et al. Human milk composition promotes optimal infant growth, development and health. Semin Perinatol. 2021;45(2): 151380.

    Article  PubMed  Google Scholar 

  41. Nommsen LA, Lovelady CA, Heinig MJ, Lönnerdal B, Dewey KG. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: the DARLING Study. Am J Clin Nutr. 1991;53(2):457–65.

    Article  CAS  PubMed  Google Scholar 

  42. Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res. 2006;45(3):203–36.

    Article  CAS  PubMed  Google Scholar 

  43. Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Brüderl M, et al. Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. Eur J Clin Nutr. 2013;67(3):282–8.

    Article  CAS  PubMed  Google Scholar 

  44. Koletzko B, von Kries R, Closa R, Escribano J, Scaglioni S, Giovannini M, et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr. 2009;89(6):1836–45.

    Article  CAS  PubMed  Google Scholar 

  45. Stokes A, Campbell KJ, Yu HJ, Szymlek-Gay EA, Abbott G, He QQ, et al. Protein Intake from Birth to 2 Years and Obesity Outcomes in Later Childhood and Adolescence: A Systematic Review of Prospective Cohort Studies. Adv Nutr. 2021;12(5):1863–76.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Singhal A, Kennedy K, Lanigan J, Fewtrell M, Cole TJ, Stephenson T, et al. Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trials. Am J Clin Nutr. 2010;92(5):1133–44.

    Article  CAS  PubMed  Google Scholar 

  47. Grunewald M, Hellmuth C, Demmelmair H, Koletzko B. Excessive Weight Gain during Full Breast-Feeding. Ann Nutr Metab. 2014;64(3–4):271–5.

    Article  CAS  PubMed  Google Scholar 

  48. Perrella SL, Geddes DT. A Case Report of a Breastfed Infant’s Excessive Weight Gains over 14 Months. J Hum Lact. 2015;32(2):364–8.

    Article  PubMed  Google Scholar 

  49. Zhang J, Zhao A, Lai S, Yuan Q, Jia X, Wang P, et al. Longitudinal Changes in the Concentration of Major Human Milk Proteins in the First Six Months of Lactation and Their Effects on Infant Growth. Nutrients. 2021;13(5):1476.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Khan S, Hepworth AR, Prime DK, Lai CT, Trengove NJ, Hartmann PE. Variation in Fat, Lactose, and Protein Composition in Breast Milk over 24 Hours: Associations with Infant Feeding Patterns. J Hum Lact. 2013;29(1):81–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK

    Mayara Vieira Queiroz De Paula, Maude Grant, Julie Lanigan & Atul Singhal

  2. Nestlé Nutrition, Société des Produits Nestlé, Vevey, Switzerland

    Maude Grant

Authors
  1. Mayara Vieira Queiroz De Paula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maude Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julie Lanigan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atul Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All researchers developed the review protocol in collaboration. MDP and MG completed literature search, selection, data extraction and bias assessments. MDP produced the original draft manuscript including all figures and tables. MDP, AS, MG and JL provided review and edits to the manuscript. AS and JL provided expertise and supervision. All authors read and agreed to the final version of the manuscript.

Corresponding author

Correspondence to Mayara Vieira Queiroz De Paula.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Atul Singhal has previously received honoraria to give lectures or attend advisory boards or for Danone, Nestle, Reckitt, Phillips, Abbott Nutrition, and several academic institutions. He has also previously received research funding from Nestle and Abbott Nutrition. Julie Lanigan has previously received honoraria to give lectures or attend advisory boards for Danone, Nestle, Abbott Nutrition and several academic institutions. She has also previously received research funding from Nestle and Abbott Nutrition. Maude Grant is an employee of Nestle Nutrition. No affiliated organisations had any role in the design, completion or write up of this review.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1. 

PRISMA 2020 Checklist. PRISMA 2020 checklist with page numbers for this systematic review.

Additional file 2. 

Literature Search. Summary of all search terms and results.

Additional file 3. 

Study Characteristics. Summary of all included study characteristics.

Additional file 4. 

Obesity Study Findings. Summary of all included studies with a measure of human milk composition and obesity. Where significant findings were found, the results were displayed.

Additional file 5.

Body Composition Study Findings. Summary of all included studies with a measure of human milk composition and measures of body composition. Where significant findings were found, the results were displayed. 

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vieira Queiroz De Paula, M., Grant, M., Lanigan, J. et al. Does human milk composition predict later risk of obesity? A systematic review. BMC Nutr 9, 89 (2023). https://doi.org/10.1186/s40795-023-00742-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40795-023-00742-9

Keywords

BMC Nutrition

ISSN: 2055-0928

Contact us